{"id":68576,"name":"SENTINEL API GROUP, INC.","slug":"sentinel-api-group-inc","state":"FL","country":"United States of America","description":"Pharmaceutical Manufacturing","totalSpending":30000,"filings":3,"yearlySpending":[{"year":2025,"income":30000}],"issues":[{"code":"HCR","display":"Health Issues"},{"code":"MAN","display":"Manufacturing"},{"code":"BUD","display":"Budget/Appropriations"},{"code":"PHA","display":"Pharmacy"},{"code":"SCI","display":"Science/Technology"},{"code":"GOV","display":"Government Issues"}],"firms":["EXECUTIVE STRATEGIES, LTD. CO."],"lobbyists":["TYLER BEAVER"],"govEntities":["Health & Human Services, Dept of (HHS)"],"sampleDescriptions":["BIOSECURE Act implementation (H.R.8333) restricting Chinese pharmaceutical supply chains and supporting domestic API manufacturing. SBIR/STTR reauthorization (S.1573, H.R.3169) for pharmaceutical manu","BIOSECURE Act implementation (H.R.8333) restricting Chinese pharmaceutical supply chains and supporting domestic API manufacturing. SBIR/STTR reauthorization (S.1573, H.R.3169) for pharmaceutical manu","BIOSECURE Act implementation (H.R.8333) restricting Chinese pharmaceutical supply chains and supporting domestic API manufacturing. SBIR/STTR reauthorization (S.1573, H.R.3169) for pharmaceutical manu","BIOSECURE Act implementation (H.R.8333) restricting Chinese pharmaceutical supply chains and supporting domestic API manufacturing. SBIR/STTR reauthorization (S.1573, H.R.3169) for pharmaceutical manu","BIOSECURE Act implementation (H.R.8333) restricting Chinese pharmaceutical supply chains and supporting domestic API manufacturing. SBIR/STTR reauthorization (S.1573, H.R.3169) for pharmaceutical manu"]}